Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Fluid strategy during surgery may change airway size, study finds

NCT ID NCT07477392

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looked at 145 adults having spine surgery lasting over 2 hours. Researchers compared standard fluid therapy (based on weight and vital signs) with goal-directed therapy (using a heart monitor to guide fluids). They measured tongue and epiglottis thickness with ultrasound to see if the fluid method made a difference. The goal was to understand how fluid management affects airway swelling, not to treat a disease.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Goal-directed fluid therapy (intravenous fluids guided by pulse pressure variation)
What this could lead to
If successful, this could help doctors choose the best fluid strategy to reduce airway swelling after long surgeries.
What could go wrong
This is a small, completed study focused on measurements, not a treatment. Results may not change practice or apply to other surgeries.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

145 people

The number who actually took part.

Started

Mar 2023

Finished

Oct 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 65 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * 18-65 years old * ASA (American Association of Anesthesiologists) I and II * Elective spine surgery in prone position * Surgeries longer than 120 minutes Exclusion Criteria: * Chronic pulmonary disease * Renal dysfunction (glomerular filtration rate \<30 ml/kg/min) * Congestive heart failure (ejection fraction ≤35%) * Serious arrhythmias * Peripheral vascular disease * Pregnance * Patients with coagulation disorders * Patients who need more than 2 intubation attempts * Prior cervical surgery * Patients with neck extension limitation * Upper respiratory tract infection in the last 3 weeks * Patients expected to have a difficult airway (Mallampati III-IV) * Patients with a body mass index (BMI) of 35 and above * Patient's refusal

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Goal-directed fluid theraphy are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Izmir Bozyaka Training and Research Hospital

    Izmir, Bozyaka, 35100, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.